Protean Bio Inc.
Publicly observedLexington, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Lexington | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Protean Bio Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | D4CNAK4ECUT9 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant25 Apr 2023Publicly observed
NIH SBIR/STTR award: IND-enabling studies of D6PV- a novel ApoC-II peptide mimetic therapeutic
USD 999,410.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant25 Apr 2023Publicly observed
NIH SBIR/STTR award: IND-enabling studies of D6PV- a novel ApoC-II peptide mimetic therapeutic
USD 999,776.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.